Piper Sandler analyst Scott Siefers maintained a Buy rating on JPMorgan Chase & Co. (JPM – Research Report) today and set a price target of ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

The bank, which owns a minority stake in Viva Wallet, can take over the company in June if its valuation falls before a ...

JPMorgan’s net income soared 50% to more than $14 billion in the fourth quarter as the bank’s profit and revenue easily beat ...

GoodRx CEO Wendy Barnes outlined the company's priorities at the 2025 JP Morgan Healthcare Conference in San Francisco.

The trend toward larger deal sizes is likely to continue as companies seek to bolster their pipelines amid a looming patent ...

In a report released today, Jason Goldberg from Barclays maintained a Buy rating on JPMorgan Chase & Co. (JPM – Research Report), with a ...

UBS increased their price target for JPMorgan shares, listed on the New York Stock Exchange (NYSE:JPM), to $287 from the ...

Teladoc Health faces pressure in a saturated telehealth market, but it's hard to ignore the virtual care company's massive ...

Analysis of JPMorgan Chase and Goldman Sachs Q4 2024 earnings forecasts, including key metrics, analyst expectations and ...

Spain’s Almirall has announced strategic plans at the 43rd JP Morgan Healthcare Conference based on expected double-digit growth within the dermatological area for Almirall’s psoriasis and atopic ...